| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |